1. Department of Epidemiology and Health Statistics, School of Public Health, Fujian Medical University, Fuzhou 350122, China
2. Institutes for Systems Genetics, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu 610041, China
Yamsek M, Ma M, Jha R, Wan Y, Li Q, Zhong F, DeLong K, Ji Z, Rohatgi R, Keenan RJ. Structural basis of regulated N-glycosylation at the secretory translocon. Nature2026; 649(8097): 777–784
[2]
National Research Council (US) Committee on Assessing the Importance and Impact of Glycomics and Glycosciences. Transforming Glycoscience: A Roadmap for the Future. Washington (DC): National Academies Press (US), 2012
[3]
Stanley P. Genetics of glycosylation in mammalian development and disease. Nat Rev Genet2024; 25(10): 715–729
[4]
Wang W. Glycomedicine: the current state of the art. Engineering (Beijing)2023; 26: 12–15
[5]
Laroy W, Contreras R, Callewaert N. Glycome mapping on DNA sequencing equipment. Nat Protoc2006; 1(1): 397–405
[6]
Trbojević-Akmačić I, Lageveen-Kammeijer GSM, Heijs B, Petrović T, Deriš H, Wuhrer M, Lauc G. High-throughput glycomic methods. Chem Rev2022; 122(20): 15865–15913
[7]
Steigmeyer AD, Lowery SC, Rangel-Angarita V, Malaker SA. Decoding extracellular protein glycosylation in human health and disease. Annu Rev Anal Chem (Palo Alto, Calif)2025; 18(1): 241–264
[8]
Ling Y, Cai F, Su T, Zhong Y, Li L, Meng B, Li G, Gong M, Yang H, Xie X, Sun Z, Zhao Y, Liu F, Zhang Y. Glycosylation in kidney diseases. Precis Clin Med2025; 8(3): pbaf017
[9]
Thaçi K, Anthony RM. The importance of IgG N-glycosylation in health, disease, and neonatal hemochromatosis. Glycosci Ther2025; 1: 100002
[10]
Lefeber DJ, Freeze HH, Steet R, Kinoshita T. Congenital disorders of glycosylation. In: Varki A, Cummings RD, Esko JD, et al. Essentials of Glycobiology. 4th ed. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press, 2022. Chapter 45
[11]
Callewaert N, Van Vlierberghe H, Van Hecke A, Laroy W, Delanghe J, Contreras R. Noninvasive diagnosis of liver cirrhosis using DNA sequencer-based total serum protein glycomics. Nat Med2004; 10(4): 429–434
[12]
Pongracz T, Mayboroda OA, Wuhrer M. The human blood N-glycome: unraveling disease glycosylation patterns. JACS Au2024; 4(5): 1696–1708
[13]
Liu S, Liu Y, Lin J, Liu BF, He Z, Wu X, Liu X. Novel insight into the etiology of Haff disease by mapping the N-glycome with orthogonal mass spectrometry. Engineering2023; 26: 63–73
[14]
Liu Y, Guo Y, Li C, Huang Z, Liu X, Xie H, Wang W, Guan L, Liu BF, Liu S, Wang G, Liu X. Serum-derived extracellular vesicle N-glycome as a new biosignature for childhood epilepsy. Engineering (Beijing)2026; 57: 126–137
[15]
Cai F, Ling Y, Zheng Q, Li L, Su T, Shen J, Wu Z, Gong M, Yang H, Zhao W, Zhang Y. Mass spectrometry-based proteomic and glycoproteomic drafts of fifteen human body fluids. bioRxiv 2025; doi:10.1101/2025.09.29.679374
[16]
Santos-Ferreira L, Martins ÁM, Duarte HO, Moia E, Costa AF, de Ru AH, Faria-Ramos I, Matos R, Barros R, Cavadas B, Silva M, Pedrosa S, Batista DA, Gomes J, Borén T, Sousa F, Casanova-Gonçalves F, Barbosa J, Magalhães A, Gomes C, Santos-Sousa H, Bartfeld S, Wuhrer M, de Haan N, Carneiro F, Reis CA, Pinto F. Patient-derived organoids to study glycosylation dynamics during gastric disease. Cell Rep2025; 44(11): 116550
[17]
Helm J, Mereiter S, Oliveira T, Gattinger A, Markovitz DM, Penninger JM, Altmann F, Stadlmann J. Non-targeted N-glycome profiling reveals multiple layers of organ-specific diversity in mice. Nat Commun2024; 15(1): 9725
[18]
Siegel SJ, Pomerantz D, Heimburg-Molinaro J, Danish Mahmood S, Korzenik JR, Cummings RD, Rakoff-Nahoum S. A glycan atlas of the mammalian intestine through ontogeny and inflammation. bioRxiv 2025; doi:10.1101/2025.03.06.641959
[19]
Parekh R, Dwek R, Sutton B, Fernandes D, Leung A, Stanworth D, Rademacher T, Mizuochi T, Taniguchi T, Matsuta K, Takeuchi F, Nagano Y, Miyamoto T, Kobata A. Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature1985; 316(6027): 452–457
[20]
Kaneko Y, Nimmerjahn F, Ravetch JV. Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science2006; 313(5787): 670–673
[21]
Sharapov S, Timoshchuk A, Zaytseva O, Maslov DE, Soplenkova A, Elgaeva EE, Tiys ES, Mangino M, Wittenbecher C, Karssen L, Timofeeva M, Nostaeva A, Vuckovic F, Trbojević-Akmačić I, Štambuk T, Feoktistova S, Potapova NA, Voroshilova V, Williams F, Primorac D, Van Zundert J, Georges M, Suhre K, Allegri M, Chaturvedi N, Dunlop M, Schulze MB, Spector T, Tsepilov YA, Lauc G, Aulchenko YS. A genome-wide association study in 10 000 individuals links plasma N-glycome to liver disease and anti-inflammatory proteins. Nat Commun2025; 16(1): 5525
[22]
Gaifem J, Rodrigues CS, Petralia F, Alves I, Leite-Gomes E, Cavadas B, Dias AM, Moreira-Barbosa C, Revés J, Laird RM, Novokmet M, Štambuk J, Habazin S, Turhan B, Gümüş ZH, Ungaro R, Torres J, Lauc G, Colombel JF, Porter CK, Pinho SS. A unique serum IgG glycosylation signature predicts development of Crohn's disease and is associated with pathogenic antibodies to mannose glycan. Nat Immunol2024; 25(9): 1692–1703
[23]
Hulbert SW, Desai P, Jewett MC, DeLisa MP, Williams AJ. Glycovaccinology: the design and engineering of carbohydrate-based vaccine components. Biotechnol Adv2023; 68: 108234
[24]
Larsen MD, de Graaf EL, Sonneveld ME, Plomp HR, Nouta J, Hoepel W, Chen HJ, Linty F, Visser R, Brinkhaus M, Šuštić T, de Taeye SW, Bentlage AEH, Toivonen S, Koeleman CAM, Sainio S, Kootstra NA, Brouwer PJM, Geyer CE, Derksen NIL, Wolbink G, de Winther M, Sanders RW, van Gils MJ, de Bruin S, Vlaar APJ, Rispens T, den Dunnen J, Zaaijer HL, Wuhrer M, Ellen van der Schoot C, Vidarsson G, van Agtmael M, Algera AG, van Baarle F, Bax D, van de Beek D, Beudel M, Bogaard HJ, Bonta PI, Bomers M, Bos L, Botta M, de Bree G, Brouwer MC, Brabander J, de Bruin S, Bugiani M, Bulle E, Chouchane O, Cloherty A, Elbers P, Fleuren L, Geerlings S, Geerts B, Geijtenbeek T, Girbes A, Goorhuis B, Grobusch MP, Hafkamp F, Hagens L, Hamann J, Harris V, Hemke R, Hermans SM, Heunks L, Hollmann MW, Horn J, Hovius JW, de Jong M, Koning R, van Mourik N, Nellen J, Nossent EJ, Paulus F, Peters E, van der Poll T, Preckel B, Prins JM, Raasveld J, Rijnders T, Schinkel M, Schultz M, Schuurmans AR, Sigaloff K, Smit M, Stijnis CS, Stilma W, Teunissen C, Thoral P, Tsonas A, van der Valk M, Veelo D, Vlaar APJ, de Vries H, van Vugt M, Wiersinga WJ, Wouters D, Zwinderman AHK. Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity. Science2021; 371(6532): eabc8378
[25]
Wang X, Zhong Z, Wang W. COVID-19 and preparing planetary health for future ecological crises: hopes from glycomics for vaccine innovation. OMICS2021; 25(4): 234–241
[26]
Lardone RD, Garay YC, Parodi P, de la Fuente S, Angeloni G, Bravo EO, Schmider AK, Irazoqui FJ. How glycobiology can help us treat and beat the COVID-19 pandemic. J Biol Chem2021; 296: 100375
[27]
Su R, Tao X, Yan L, Liu Y, Chen CC, Li P, Li J, Miao J, Liu F, Kuai W, Hou J, Liu M, Mi Y, Xu L. Early screening, diagnosis and recurrence monitoring of hepatocellular carcinoma in patients with chronic hepatitis B based on serum N-glycomics analysis: a cohort study. Hepatology2026; 83(1): 40–56